Introduction: BRIP1 (BRCA1-interacting protein 1) is one of the major interacting partners of BRCA1, which plays an important role in repair by homologous recombination (HR). This gene is mutated in around 4% of cases of breast cancer; however, its mechanism of action is unclear. In this study, we presented the fundamental role of BRCA1 interactors BRIP1 and RAD50 in the development of differential severity in triple-negative breast cancer (TNBC) among various affected individuals.Methods: We have analyzed the expression of DNA repair-related genes in different BC cells using Real-time PCR and western blotting analysis and assessed changes in stemness property and proliferation through Immunophenotyping. We have performed cell cycle analysi...
BRIP1 is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breast cancer...
BRCA1 L1780P BRCT domain mutation has been recognized as a pathogenic mutation in patients with brea...
BRIP1 is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breast cancer...
Introduction: BRIP1 (BRCA1-interacting protein 1) is one of the major interacting partners of BRCA1,...
Breast cancer (BC) is the most common malignancy and the leading cause of death in women worldwide. ...
Germline mutations in BRCA1 gene confer the highest lifetime risks to develop breast and ovarian can...
BRCA1 is a large multi-domain protein with a pivotal role in maintaining genome stability and cell c...
BRIP1 is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breast cancer...
Triple negative (TN) breast cancers make up some 15% of all breast cancers. Approximately 10-15% are...
<div><p>BRIP1 is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breas...
Breast cancer is one of the leading causes of death worldwide, and therefore, new and improved appro...
Triple negative (TN) breast cancers make up some 15% of all breast cancers. Approximately 10-15% are...
In Oman, breast cancer is most common, representing approximately more than 25% of all cancers in wo...
BRIP1 (Breast Cancer 1 Interacting Helicase 1) is a tumor suppressor gene that has vital function in...
BRIP1 is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breast suscep...
BRIP1 is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breast cancer...
BRCA1 L1780P BRCT domain mutation has been recognized as a pathogenic mutation in patients with brea...
BRIP1 is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breast cancer...
Introduction: BRIP1 (BRCA1-interacting protein 1) is one of the major interacting partners of BRCA1,...
Breast cancer (BC) is the most common malignancy and the leading cause of death in women worldwide. ...
Germline mutations in BRCA1 gene confer the highest lifetime risks to develop breast and ovarian can...
BRCA1 is a large multi-domain protein with a pivotal role in maintaining genome stability and cell c...
BRIP1 is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breast cancer...
Triple negative (TN) breast cancers make up some 15% of all breast cancers. Approximately 10-15% are...
<div><p>BRIP1 is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breas...
Breast cancer is one of the leading causes of death worldwide, and therefore, new and improved appro...
Triple negative (TN) breast cancers make up some 15% of all breast cancers. Approximately 10-15% are...
In Oman, breast cancer is most common, representing approximately more than 25% of all cancers in wo...
BRIP1 (Breast Cancer 1 Interacting Helicase 1) is a tumor suppressor gene that has vital function in...
BRIP1 is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breast suscep...
BRIP1 is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breast cancer...
BRCA1 L1780P BRCT domain mutation has been recognized as a pathogenic mutation in patients with brea...
BRIP1 is a DNA helicase that directly interacts with the C-terminal BRCT repeat of the breast cancer...